Epigenetic editing tags hepatitis B genome to shut down viral activity
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Scientists at nChroma Bio in Boston and institutes in Milan used epigenetic editing to place chemical tags on the hepatitis B virus genome, blocking viral gene activity without the cancer risks linked to DNA-cutting gene therapies. Tests in human liver cells, mice and monkeys showed promising results with only minimal temporary side effects. The study was published in Nature Biomedical Engineering on 21 September. HBV affects more than 250 million people worldwide, and current drugs often fail to eradicate it.
Continue in the app — vote & join in ➔Source: Nature News · via ahirlevel.hu